针对慢性阻塞性肺病药物治疗的当前概念:朝着个性化管理取得进展
Prescott G Woodruff1, Alvar Agusti2, Nicolas Roche3
1Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, CA, USA.
Lancet (London, England)
|May 7, 2015
概括
了解慢性阻塞性肺病 (COPD) 需要识别患者的子组. 用生物标志物准特定的内型将促进个性化COPD治疗和药物开发.
科学领域:
- 肺部医学 肺部医学
- 翻译研究 翻译研究
- 生物标志物发现发现
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂,异质的呼吸系统疾病,具有重大的全球健康和经济影响.
- 目前的治疗指南将COPD管理分为改善症状和降低风险,朝着个性化医疗方向发展.
- 临床表型虽然有用,但可以重叠,并可能源于不同的生物机制,需要更深入的理解.
研究的目的:
- 探索COPD内型的概念作为不同的病理生理学亚型.
- 强调确定这些内型的特定生物标志物的重要性.
- 讨论以内型为基础的方法如何完善COPD的临床实践和药物开发.
主要方法:
- 审查当前的COPD指南和治疗策略.
- 讨论临床表型在指导个性化医学的局限性.
- 探索新兴概念,如内型和疾病复杂性的网络分析.
主要成果:
- 临床表型可能无法完全捕捉COPD的生物异质性.
- 通过验证的生物标志物向特定的内型,有望为更有效的疗法提供希望.
- 针对特定炎症途径的新兴药物需要内型和生物标志物识别才能获得试验成功.
结论:
- 对COPD的个性化治疗需要转向了解和准潜在的内型.
- 生物标志物对于识别内型和使COPD精准医学成为可能至关重要.
- 网络分析和进一步的研究对于重新分类COPD等复杂疾病和开发新疗法至关重要.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.4K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K